ADMP News and Press, Adamis Pharmaceuticals Corporation From 05/19/23

2023-05-19 12:34:48 ET Adamis Pharmaceuticals ( NASDAQ: ADMP ) fell ~19% on Friday after announcing plans to effect a 1-for-70 reverse stock split of its common stock from next week. Accordingly, the reverse stock split will take effect on May 22, 2023, at 12:01 a.m., and ...

SAN DIEGO, May 19, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, announced today that it will effect a 1-for-70 reverse stock split of its common stock that will become effective on May 22, 2023, at 12:01 a.m., Easter...

2023-05-15 18:32:06 ET Adamis Pharmaceuticals Corporation (ADMP) Q1 2023 Earnings Conference Call May 15, 2023, 05:00 PM ET Company Participants Robert Uhl - MD, ICR Westwicke David Marguglio - CEO David Benedicto - CFO Eboo Versi - CEO, DMK Pharmaceuticals ...

2023-05-15 16:51:04 ET Adamis Pharmaceuticals press release ( NASDAQ: ADMP ): Q1 GAAP EPS of -$0.06. Revenue of $1.45M (+20.8% Y/Y). For further details see: Adamis Pharmaceuticals GAAP EPS of -$0.06, revenue of $1.45M

SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease...

2023-05-12 10:44:38 ET Major earnings expected before the bell on Monday include: Adamis Pharmaceuticals ( ADMP ) CV Sciences ( OTCQB:CVSI ) Sundial Growers ( SNDL ) Sunworks ( SUNW ) Workhorse Group ( WKHS ) For further details see: Notab...

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammato...

2023-03-17 16:50:24 ET Adamis Pharmaceuticals Corporation (ADMP) Q4 2022 Results Conference Call March 16, 2023 05:00 PM ET Company Participants Robert Uhl - MD, ICR Westwicke David Marguglio - CEO David Benedicto - CFO Dr. Eboo Versi - CEO, DMK Pharmaceutica...

2023-03-16 16:32:25 ET Adamis Pharmaceuticals press release ( NASDAQ: ADMP ): FY GAAP EPS of -$0.18. Revenue of $4.75M (+115.9% Y/Y). For further details see: Adamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75M

SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announc...